Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina

• Asıl Yazarlar: Suada Heljic (Yazar), Hajrija Maksic (Yazar), Hidajeta Begic (Yazar), Fahrija Skokic (Yazar), Darinka Glamuzina (Yazar), Tomica Bozic (Yazar), Stojislav Konjevic (Yazar), Veroslava Milosevic (Yazar), Sabina Terzic (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Hygeia Press di Corridori Marinella, 2016-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Palivizumab is indicated for respiratory syncytial virus (RSV) prophylaxis in high-risk children. Methods: Observational study, based on 4 sites in Bosnia and Herzegovina (B&H), with institutional reports of infants at high risk for RSV who received at least 1 dose of palivizumab dur...